Healthy Adult Participants research hub
10 indexed studies · 4 currently recruiting
- recruitingPHASE1, PHASE2
RIG 101 Trial in Healthy Adults and Adults With Asthma
This study is testing a new medicine, RIG-101, for asthma attacks triggered by colds. We want to see if it's safe, and if it helps people with asthma and healthy volunteers. It combines early safety checks with later tests of how well it works.
United Kingdom - recruitingPHASE1
Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy Participants
This study is looking at a new medicine called ALXN2230 in healthy adults. We want to see if it's safe, how well the body handles it, and how it moves through the body. This is a very early stage of testing.
United Kingdom - not yet recruitingNA
Fluoxetine and Understanding Social Experiences
This study looks at how the antidepressant fluoxetine (Prozac) affects how young people aged 18-24 make social decisions. We want to understand how it impacts emotions, social interactions, and motivation. This helps us learn more about how antidepressants work in young adults.
United Kingdom - recruitingPHASE1
Phase 1 Study of ADX-626 in Healthy Participants
This study is looking for healthy adults aged 18-45 to test a new medicine called ADX-626. It's the very first time this medicine will be given to people. We want to see if it's safe and how it works in the body.
United Kingdom - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study to evaluate the effect of multiple doses of carbamazepine on how long aticaprant (JNJ-67953964) stays in the body (pharmacokinetics) in healthy adults
Belgium - ongoing, recruitingHuman Pharmacology (Phase I)- Other
An Open-label, Single-dose, Parallel-group Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Aticaprant (JNJ-67953964)
Germany - ongoing, recruitingHuman Pharmacology (Phase I)- Other
An Open-Label, Single-Center, Single-Dose Study to Assess the Absolute Oral Bioavailability and Pharmacokinetics of Aticaprant Administered as an Oral Tablet and an Intravenous Infusion Microdose of 14C-Aticaprant in Healthy Participants
Belgium - ongoing, recruitingHuman Pharmacology (Phase I)- Other
An Open-label, Single-dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Aticaprant (JNJ-67953964)
Germany - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without rabeprazole.
Belgium - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study in healthy volunteers to find out how long aticaprant stays in and acts on the body when administered with or without food and with or without fluconazole
Belgium